Leonardo Barbarini Selected Research

Dabigatran

1/2023	Thrombolysis after dabigatran reversal: A nation-wide Italian multicentre study, systematic review and meta-analysis.
1/2020	Dabigatran initiation in patients with non-valvular AF and first acute ischaemic stroke: a retrospective observational study from the SITS registry.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Leonardo Barbarini Research Topics

Disease

4	Ischemic Stroke 01/2024 - 01/2020
4	Stroke (Strokes) 10/2023 - 01/2020
1	Cerebral Hemorrhage 01/2024
1	Heart Failure 10/2023
1	Hypertension (High Blood Pressure) 01/2023
1	Critical Illness (Critically Ill) 07/2021
1	Atrial Fibrillation 01/2020
1	Fabry Disease (Fabry's Disease) 09/2018

Drug/Important Bio-Agent (IBA)

2	EnzymesIBA 01/2024 - 09/2018
2	Dabigatran FDA Link 01/2023 - 01/2020
1	GalactosidasesIBA 01/2024
1	idarucizumabIBA 01/2023
1	dimemorfan (AT 17)IBA 01/2023
1	AnticoagulantsIBA 01/2023
1	GangliosidesIBA 07/2021
1	AntibodiesIBA 07/2021
1	4- Acetamido- 4'- isothiocyanatostilbene- 2,2'- disulfonic Acid (SITS)IBA 01/2020
1	alpha-Galactosidase (Beano)IBA 09/2018
1	GlycosphingolipidsIBA 09/2018

Therapy/Procedure

2	Thrombectomy 10/2023 - 01/2020
1	Contraindications 01/2023
1	Secondary Prevention 04/2022